Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03108131
Title Cobimetinib and Atezolizumab in Advanced Rare Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

Advanced Solid Tumor

small intestine adenocarcinoma

appendix adenocarcinoma

skin squamous cell carcinoma


Atezolizumab + Cobimetinib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.